ArticleJournal of dermatological science2021
Corrigendum to 'SJS/TEN 2019: From science to translation' [J. Dermatol. Sci. 98/1 (2020) 2-12].
Abstract readPublished Erratum
In one paragraph
Article in Journal of dermatological science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Spectrum of offending drugs and cutaneous adverse drug reactions requiring hospitalisation in a tertiary South African hospital in TB/HIV endemic setting.Frontiers in allergy · 2024Article
- Stevens Johnson Syndrome: Past, Present, and Future Directions Gynecologic Manifestations and Management in SJS/TEN.Frontiers in medicine · 2022Article
Corrections and comments
- Erratum for
Authors and funding
70 authors.
Wan-Chun ChangDivision of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada; British Columbia Children's Hospital Research Institute, Vancouver, BC, Canada.
Riichiro AbeNiigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Paul AndersonStevens-Johnson Syndrome Foundation, Westminster, CO, USA.
Wanpen AndersonStevens-Johnson Syndrome Foundation, Westminster, CO, USA.
Michael R Ardern-JonesFaculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, UK.
Thomas M BeachkofskyWilford Hall Ambulatory Surgical Center, Lackland Air Force Base, TX, USA.
Teresa BellónDrug Hypersensitivity Group. Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
Agnieszka K BialaDivision of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
Charles BouchardLoyola University Medical Center, Chicago, IL, USA.
Gianpiero L CavalleriSchool of Pharmacy and Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland; FutureNeuro SFI Research Centre, Royal College of Surgeons in Ireland, Dublin, Ireland.
Nicole ChapmanSJS Awareness Oregon, Klamath Falls, OR, USA.
James ChodoshMassachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.
Hyon K ChoiDivision of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA, USA.
Ricardo R CibottiNational Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, USA.
Sherrie J DivitoDepartment of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Karen DewarGenome Canada, Ottawa, ON, Canada.
Ulrike DehaeckDepartment of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada.
Mahyar EtminanDepartment of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, BC, Canada.
Diane ForbesCanadian Institutes of Health Research, Ottawa, ON, Canada.
Esther FuchsDepartment of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA.
Jennifer L GoldmanChildren's Mercy Hospital Kansas City, Kansas City, MO, USA.
James H HolmesWake Forest University School of Medicine, WFBMC Burn Center, Winston-Salem, NC, USA.
Elyse A HopeGenome British Columbia, Vancouver, BC, Canada.
Shuen-Iu HungCancer Vaccine and Immune Cell Therapy Core Laboratory, Chang Gung Immunology Consortium, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan; Institute of Pharmacology, National Yang-Ming University, Taipei, Taiwan.
Chia-Ling HsiehEden Social Welfare Foundation, Taipei, Taiwan.
Alfonso IovienoDepartment of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver General Hospital Eye Care Center, Vancouver, BC, Canada.
Julienne JagdeoGenome British Columbia, Vancouver, BC, Canada.
Mee Kum KimDepartment of Ophthalmology, Seoul National University College of Medicine, Seoul, South Korea.
David M KoelleDepartment of Medicine, University of Washington, Seattle, WA, USA.
Mario E LacoutureMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Sophie Le PallecAssociation des malades des syndromes de Lyell et de Stevens-Johnson (Amalyste), Paris, France.
Rannakoe J LehloenyaDivision of Dermatology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
Robyn LimHealth Products and Food Branch, Health Canada, Ottawa, ON, Canada.
Angie LoweSJS/TEN International Awareness (STIA), Lucky Lake, SK, Canada.
Jean McCawleyStevens-Johnson Syndrome Foundation, Westminster, CO, USA.
Julie McCawleyStevens-Johnson Syndrome Foundation, Westminster, CO, USA.
Robert G MichelettiDepartment of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Maja MockenhauptDokumentationszentrum schwerer Hautreaktionen (dZh), Department of Dermatology, Medical Center and Medical Faculty, University of Freiburg, Freiburg, Germany.
Katie NiemeyerSJ Syndrome of Texas, Austin, TX, USA.
Michael A NorcrossLaboratory of Immunology, Division of Biotechnology Review and Research III (DBRR III), Office of Biotechnology Products (OBP), Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), FDA, Silver Spring, MD, USA.
Douglas ObohStevens-Johnson Syndrome Foundation, Westminster, CO, USA.
Cristina OlteanuDivision of Dermatology, Department of Medicine, University of Alberta, Edmonton, AB, Canada.
Helena B PasiekaDepartment of Der matology, MedStar Washington Hospital Center, Washington, DC, USA.
Jonathan PeterDivision of Allergy and Clinical Immunology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
Munir PirmohamedDepartment of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.
Michael RiederDepartment of Paediatrics, Children's Hospital/London Health Sciences Centre, Schulich School of Medicine & Dentistry, Western University, London, ON, Canada.
Hajirah N SaeedMassachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.
Neil H ShearSunnybrook Health Sciences Centre, University of Toronto, ON, Canada.
Christine ShiehDepartment of Ophthalmology, Vanderbilt Eye Institute, Nashville, TN, USA.
Sabine StrausDutch Medicines Evaluation Board, Pharmacovigilance Risk Assessment Committee, European Medicines Agency, Utrecht, Netherlands.
Chonlaphat SukasemRamathibodi Hospital, Mahidol University, Bangkok, Thailand.
Cynthia SungHealth Products Regulation Group, Health Sciences Authority Singapore, Duke-NUS Medical School, Singapore.
Jason A TrubianoDepartment of Infectious Diseases, Austin Health, Heidelberg, Germany; Department of Medicine, University of Melbourne, Victoria, Australia.
Sheng-Ying TsouEden Social Welfare Foundation, Taipei, Taiwan.
Mayumi UetaDepartment of Frontier Medical Science and Technology for Ophthalmology, Kyoto Pre fectural University of Medicine, Kyoto, Japan.
Simona VolpiNational Human Genome Research Institute, NIH, Bethesda, ML, USA.
Chen WanGenome British Columbia, Vancouver, BC, Canada.
Hongsheng WangInstitute of Dermatology, Chinese Academy of Medical Sciences, National Center for STD and Leprosy Control, China CDC, Nanjing, China.
Zhao-Qing WangEden Social Welfare Foundation, Taipei, Taiwan.
Jessica WeintraubDivision of Pharmacovigilance I, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, USA.
Cindy WhaleSJS Canada, Brantford, ON, Canada.
Lisa M WheatleyNational Institute of Allergy and Infectious Diseases, NIH, Bethesda, ML, USA.
Sonia Whyte-CroasdaileSJS Canada, Brantford, ON, Canada.
Kristina B WilliamsDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Galen WrightDivision of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
Sonia N YeungDepartment of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver General Hospital Eye Care Center, Vancouver, BC, Canada.
Li ZhouDivision of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Wen-Hung ChungDepartment of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou, Taipei, Keelung, Taoyuan, Taiwan; Cancer Vaccine and Immune Cell Therapy Core Laboratory, Chang Gung Immunology Consortium, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan; College of Medicine, Chang Gung University, Taoyuan, Taiwan; Whole-Genome Research Core Laboratory of Human Diseases, Chang Gung Memorial Hospital, Keelung, Taiwan; Department of Dermatology, Xiamen Chang Gung Hospital, Xiamen, China.
Elizabeth J PhillipsDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Australia; Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA.
Bruce C CarletonDivision of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada; British Columbia Children's Hospital Research Institute, Vancouver, BC, Canada. Electronic address: bcarleton@popi.ubc.ca.
Funding
Clinical Informatics to Advance Epidemiology and Pharmacogenetics of Serious Cutaneous Adverse Drug ReactionsR01AI150295 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI ZHOU, LI · 2019 to 2022
$2.8MInvestigating a novel cell population in delayed-onset drug hypersensitivity reactionsDP5OD023091 · OD · BRIGHAM AND WOMEN'S HOSPITAL · PI DIVITO, SHERRIE JILL · 2016 to 2020
$2.1MInvestigating mechanisms of epidermal cell death in Toxic Epidermal NecrolysisR21AI150657 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI DIVITO, SHERRIE JILL · 2020 to 2021
$492kMedical Research Council MR/L006758/1NIAID NIH HHS R01 AI150295NIAID NIH HHS R21 AI150657NIH HHS DP5 OD023091
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.